Gaggioli Andrea, Pallavicini Federica, Morganti Luca, Serino Silvia, Scaratti Chiara, Briguglio Marilena, Crifaci Giulia, Vetrano Noemi, Giulintano Annunziata, Bernava Giuseppe, Tartarisco Gennaro, Pioggia Giovanni, Raspelli Simona, Cipresso Pietro, Vigna Cinzia, Grassi Alessandra, Baruffi Margherita, Wiederhold Brenda, Riva Giuseppe
Applied Technology for Neuro-Psychology Lab, Istituto Auxologico Italiano, Milan, Italy.
J Med Internet Res. 2014 Jul 8;16(7):e167. doi: 10.2196/jmir.3235.
The recent convergence between technology and medicine is offering innovative methods and tools for behavioral health care. Among these, an emerging approach is the use of virtual reality (VR) within exposure-based protocols for anxiety disorders, and in particular posttraumatic stress disorder. However, no systematically tested VR protocols are available for the management of psychological stress.
Our goal was to evaluate the efficacy of a new technological paradigm, Interreality, for the management and prevention of psychological stress. The main feature of Interreality is a twofold link between the virtual and the real world achieved through experiential virtual scenarios (fully controlled by the therapist, used to learn coping skills and improve self-efficacy) with real-time monitoring and support (identifying critical situations and assessing clinical change) using advanced technologies (virtual worlds, wearable biosensors, and smartphones).
The study was designed as a block randomized controlled trial involving 121 participants recruited from two different worker populations-teachers and nurses-that are highly exposed to psychological stress. Participants were a sample of teachers recruited in Milan (Block 1: n=61) and a sample of nurses recruited in Messina, Italy (Block 2: n=60). Participants within each block were randomly assigned to the (1) Experimental Group (EG): n=40; B1=20, B2=20, which received a 5-week treatment based on the Interreality paradigm; (2) Control Group (CG): n=42; B1=22, B2=20, which received a 5-week traditional stress management training based on cognitive behavioral therapy (CBT); and (3) the Wait-List group (WL): n=39, B1=19, B2=20, which was reassessed and compared with the two other groups 5 weeks after the initial evaluation.
Although both treatments were able to significantly reduce perceived stress better than WL, only EG participants reported a significant reduction (EG=12% vs. CG=0.5%) in chronic "trait" anxiety. A similar pattern was found for coping skills: both treatments were able to significantly increase most coping skills, but only EG participants reported a significant increase (EG=14% vs CG=0.3%) in the Emotional Support skill.
Our findings provide initial evidence that the Interreality protocol yields better outcomes than the traditionally accepted gold standard for psychological stress treatment: CBT. Consequently, these findings constitute a sound foundation and rationale for the importance of continuing future research in technology-enhanced protocols for psychological stress management.
ClinicalTrials.gov: NCT01683617; http://clinicaltrials.gov/show/NCT01683617 (Archived by WebCite at http://www.webcitation.org/6QnziHv3h).
近期技术与医学的融合为行为健康护理提供了创新方法和工具。其中,一种新兴方法是在基于暴露的焦虑症治疗方案中使用虚拟现实(VR),尤其是创伤后应激障碍。然而,目前尚无经过系统测试的VR方案用于心理压力管理。
我们的目标是评估一种新的技术范式——交互现实(Interreality)在心理压力管理和预防方面的疗效。交互现实的主要特点是通过体验性虚拟场景(完全由治疗师控制,用于学习应对技能和提高自我效能)与使用先进技术(虚拟世界、可穿戴生物传感器和智能手机)进行实时监测和支持(识别关键情况并评估临床变化),在虚拟世界与现实世界之间建立双重联系。
该研究设计为一项整群随机对照试验,招募了121名来自两个不同职业群体(教师和护士)的参与者,他们都高度暴露于心理压力之下。参与者包括在米兰招募的教师样本(第1组:n = 61)和在意大利墨西拿招募的护士样本(第2组:n = 60)。每个组内的参与者被随机分配到:(1)实验组(EG):n = 40;第1组 = 20,第2组 = 20,接受基于交互现实范式的为期5周的治疗;(2)对照组(CG):n = 42;第1组 = 22,第2组 = 20,接受基于认知行为疗法(CBT)的为期5周的传统压力管理培训;(3)等待列表组(WL):n = 39,第1组 = 19,第2组 = 20,在初始评估5周后重新评估并与其他两组进行比较。
尽管两种治疗方法都能比等待列表组更显著地减轻感知压力,但只有实验组参与者报告慢性“特质”焦虑有显著降低(实验组 = 12% 对对照组 = 0.5%)。应对技能方面也发现了类似模式:两种治疗方法都能显著提高大多数应对技能,但只有实验组参与者报告情绪支持技能有显著提高(实验组 = 14% 对对照组 = 0.3%)。
我们的研究结果提供了初步证据,表明交互现实方案在心理压力治疗方面比传统公认的金标准——认知行为疗法(CBT)产生更好的效果。因此,这些发现为继续开展技术增强的心理压力管理方案的未来研究的重要性奠定了坚实基础和理论依据。
ClinicalTrials.gov:NCT01683617;http://clinicaltrials.gov/show/NCT01683617(由WebCite存档于http://www.webcitation.org/6QnziHv3h)